The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Forecasted Market Size Of The Convalescent Plasma Therapy Market Compare Between 2026 And 2030?
The market size for convalescent plasma therapy has experienced swift expansion in recent years. It is forecast to increase from $0.06 billion in 2025 to $0.06 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.6%. Historically, this expansion can be ascribed to factors such as the pressing demand for pandemic treatment, a scarcity of targeted therapeutics, the availability of recovered donors, emergency use authorizations, and widespread hospital-based plasma transfusion.
The convalescent plasma therapy market is projected to experience substantial expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $0.11 billion, demonstrating a compound annual growth rate (CAGR) of 13.5%. Key factors contributing to this growth during the forecast period include enhanced readiness for future disease outbreaks, breakthroughs in antibody testing, refinements in plasma storage methods, the broadening of transfusion service accessibility, and ongoing research into various immune therapies. Significant trends observed within the forecast timeframe encompass the rising application in treating emerging infectious diseases, an increasing emphasis on high-titer antibody plasma, the expansion of facilities for plasma collection, more effective donor screening and selection processes, and its integration into critical care units within hospitals.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp
Which Strategic Drivers Are Supporting The Convalescent Plasma Therapy Market Development?
The increasing occurrence of infectious diseases is anticipated to boost the expansion of the Convalescent Plasma Therapy market. These diseases, caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, spread between individuals or via polluted surroundings. Their increasing incidence stems from heightened urbanization and worldwide travel, fostering closer human interaction and quicker pathogen dissemination. Convalescent plasma therapy aids in fighting these illnesses by utilizing plasma from recovered individuals, which possesses antibodies capable of neutralizing pathogens and offering passive immunity to currently infected patients, thereby strengthening the body’s defense. For example, the World Health Organization (WHO) reported in October 2024 that new tuberculosis diagnoses reached approximately 8.2 million in 2023, an increase from 7.5 million in 2022, marking the highest figure since global TB surveillance commenced. Consequently, the growing prevalence of infectious diseases is a key factor propelling the Convalescent Plasma Therapy market.
How Is The Convalescent Plasma Therapy Market Distributed Across Key Segments?
The convalescent plasma therapy market covered in this report is segmented –
1) By Antibody type: IgM, IgG, IgA
2) By Application: Prophylaxis, Treatment
3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes
Subsegments:
1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma
2) By IgG: High Titer IgG Plasma, Standard IgG Plasma
3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma
Which Trends Are Expected To Shape The Convalescent Plasma Therapy Market?
Major companies in the convalescent plasma therapy market are concentrating on developing innovative solutions, such as hyperimmune globulin therapies, to boost treatment efficacy and tackle issues associated with standard plasma therapies. Hyperimmune Globulin Therapies are treatments that use plasma with a high concentration of specific antibodies, derived from individuals who have recovered from an infection, to provide targeted and powerful immune support for patients. For instance, in October 2023, Kamada Ltd., an Israel-based biopharmaceutical company, announced significant progress concerning its product CYTOGAM (Cytomegalovirus Immune Globulin Intravenous [Human]), which is now commercially available in the U.S. after FDA approval for its manufacturing facility in Israel. At IDWeek 2023, fresh clinical data showed a five-year survival benefit for high-risk CMV mismatch lung transplant patients receiving CYTOGAM. Additionally, Kamada has established its first Scientific Advisory Board to enhance U.S. clinical programs for the product.
Which Companies Are Engaged In The Convalescent Plasma Therapy Market Environment?
Major companies operating in the convalescent plasma therapy market are Bio Farma, Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank, Kedrion Biopharma Inc.
Access The Complete Convalescent Plasma Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report
Which Region Commands The Largest Share Of The Convalescent Plasma Therapy Market?
North America was the largest region in the convalescent plasma therapy market in 2025. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Convalescent Plasma Therapy Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp
Browse Through More Reports Similar to the Global Convalescent Plasma Therapy Market 2026, By The Business Research Company
Contrast Media Injectors Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/contrast-media-injectors-global-market-report
Medical Imaging Equipment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-imaging-equipment-global-market-report
Interventional Neurology Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
